We are live on ! Find out more
MD icon

Pediatrix Medical

220 hedge funds and large institutions have $2.38B invested in Pediatrix Medical in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 69 increasing their positions, 93 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 18

5% more call options, than puts

Call options by funds: $5.53M | Put options by funds: $5.27M

0% more funds holding

Funds holding: 220220 (0)

5.14% less ownership

Funds ownership: 102.6%97.47% (-5.1%)

10% less capital invested

Capital invested by funds: $2.66B → $2.38B (-$275M)

26% less repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 93

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
220
Holders Change
Holders Change %
0%
% of All Funds
3.85%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
20
Increased
69
Reduced
93
Closed
18
Calls
$5.53M
Puts
$5.27M
Net Calls
+$264K
Net Calls Change
+$2.18M

MD Hedge Fund Activity: Q3 2021 in Review

220 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q3 2021, worth a combined $2.38B — down 10% from $2.66B a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new MD positions and 18 closed out — a net gain of 2 holders — while 69 added to existing stakes and 93 trimmed.

The largest buyer was CAAS Capital Management, opening a new position worth an estimated $8.57M. The largest seller was Starboard Value, cutting an estimated $77.2M.

  • 220 institutional investors held Pediatrix Medical (MD) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $2.38B of Pediatrix Medical stock for Q3 2021, down 10% quarter-over-quarter.
  • 20 funds opened new Pediatrix Medical positions in Q3 2021 and 18 closed out, a net change of +2 holders.
  • The largest Pediatrix Medical buyer in Q3 2021 was CAAS Capital Management, an estimated $8.57M added.
  • The largest Pediatrix Medical seller in Q3 2021 was Starboard Value, an estimated $77.2M sold.

Based on aggregated 13F filings for Q3 2021.